Global Neuroscience Initiative Foundation
From Wikipedia, the free encyclopedia
 |
The creator of this article, or someone who has substantially contributed to it, may have a conflict of interest regarding its subject matter. |
 |
It has been suggested that GNIF Brain Blogger be merged into this article or section. (Discuss) |
| This article may not meet the general notability guideline or one of the following specific guidelines for inclusion on Wikipedia: Biographies, Books, Companies, Fiction, Music, Neologisms, Numbers, Web content, or several proposals for new guidelines. If you are familiar with the subject matter, please expand or rewrite the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for redirection, merge or ultimately deletion, per Wikipedia:Guide to deletion. This article has been tagged since February 2008. |
The Global Neuroscience Initiative Foundation (GNIF) is an international registered public 501(c)(3) charity founded in 2003 by Shaheen Lakhan, who serves as the Executive Director. With headquarters in Los Angeles, the organization participates in research and applications in health promotion and awareness, and plays scientific roles on neurological and mental illness research and education. Since its inception with an international Board of Directors and Advisors, GNIF reaches the global spectrum of afflicted individuals with various governmental (EPA, NIMHANS, Peace Corps), business (AILM, MedYX), and nonprofit (NCSD) partnerships, educational projects, research studies, and health advocacy campaigns.
The paramount GNIF mission is the betterment of neurological and mental health patient welfare, research, and education. The organization invested much of its donations to the development of novel free and open-access Therapeutic Recreational Centers, health promotion campaigns, and other charitable activities throughout the world to aid diagnosed individuals and their advocates. In 2004, they released health promotion flyers in schizophrenia, bipolar, Alzheimer's disease, and Parkinson's disease. By 2005, the organization invested in global biotechnology focusing on China's development of modern biotechnology.[1] To redefine its scientific focus, the GNIF established a proteomics core in 2006 and released a guiding scholarly article on their biomedical research practice with proteomic technologies on schizophrenia biomarkers.[2] The organization's more recent articles confirms interest in psychological research,[3][4] neurology,[5] nutrition,[6] and psychiatry.[7] Moreover, the education division of the GNIF released a thorough article on intellectual property education worldwide.[8]
By presenting free and open-access information and educational courses via a distance, GNIF aims to educate clinicians, teachers, scientists, patients, and the general public on neuroscience, medicine, psychology, biotechnology, and computer science. By partnering with the National Council for Support of Disability Issues, they have delivered free online personal development courses to thousands of individuals with disabilities from improving interview skills to managing stress and illness with physical interventions.
GNIF supports a variety of research programs ranging from biomedical to spiritual studies on the nature of the mind-body connection, biopsychosocial model of health and disease, and health psychology/behavioral medicine practices. Recently, GNIF director Shaheen Lakhan interviewed Prof. John Finberg, co-developer of the anti-Parkinson drug rasagiline.[9] By establishing the GNIF Brain Blogger news resource, they have administered many Ethics in Mental Health campaigns against mental health stigmatization and discrimination.
[edit] References
- ^ Lakhan SE. The Emergence of Modern Biotechnology in China. Issues in Informing Science and Information Technology 2006;3:333-353.
- ^ Lakhan SE. Schizophrenia proteomics: biomarkers on the path to laboratory medicine? Diagnostic Pathology 2006;1(11)
- ^ Lakhan SE. Neuropsychological Generation of Source Amnesia: An Episodic Memory Disorder of the Frontal Brain. Journal of Medical and Biological Sciences 2007;1(1).
- ^ Lakhan SE. Prescribing Privileges for Psychologists: A Public Service or Hazard?. Online Journal of Health and Allied Sciences 2007;6(1):1.
- ^ Lakhan SE; Gross K. Progressive neuroacanthocytosis in brothers: a case report. Clinics 2007,62(5):665-668.
- ^ Lakhan SE; Vieira KF. Nutritional therapies for mental disorders. Nutrition Journal 2008;7(2).
- ^ Lakhan SE; Hagger-Johnson G. The impact of prescribed psychotropics on youth. Clinical Practice and Epidemiology in Mental Health 2007;3(21).
- ^ Lakhan SE; Khurana MK. The state of intellectual property education worldwide. Journal of Academic Leadership 2007;5(2).
- ^ Lakhan SE. From a Parkinson's disease expert: Rasagiline and the Future of Therapy. Molecular Neurodegeneration 2007;2(13).
